Skip to main
GENB

GENB Market Capitalization Overview

Market Cap: $1.56B as of Mar 10, 2026

$1.56B
As of Mar 10, 2026, GENB has a market capitalization of $1.56B. Over the past 30 days, its market cap has decreased by -62.03%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Generate Biomedicines Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GENB Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GENB helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GENB Market Cap History

DateMarket CapChange

GENB End of Year Market Cap History

DateMarket CapChange
2026$1.56B

FAQs About Generate Biomedicines Inc (GENB) Market Cap

As of Mar 10, 2026, the market capitalization of GENB is $1.56B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Generate Biomedicines Inc’s market capitalization has increased by —, changing from – to $1.56B as of Mar 10, 2026.

In the last 3 months, Generate Biomedicines Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Generate Biomedicines Inc’s market capitalization increased from – in January to – in December, reflecting a — change.

Generate Biomedicines Inc (GENB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.